Search Results 631-640 of 37915 for Two-phase

  1. A Study of the Safety and Effectiveness of ADS-5102 in Patients with Multiple Sclerosis and a Walking Impairment - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. AMBER-HFpEF: Assessment Of CK-4021586 In A Multi-Center, Blinded Evaluation Of Safety And Tolerability Results In HFpEF - Mayo Clinic

    This is a Phase 2 dose-finding study in adult participants with symptomatic HFpEF. Participation eligibility. Participant eligibility includes age, gender ...

  3. Hodgkin lymphoma (Hodgkin disease) - Symptoms and causes - Mayo Clinic

    Hodgkin lymphoma (Hodgkin disease) · Request an Appointment · Symptoms & causes · Diagnosis & treatment · Stages ... Lymphoma types are often divided into two ...

  4. A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS) - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH - Mayo Clinic

    It will consist of 2 phases: Randomized Double-Blind Phase; Open Label Phase (optional). Participation eligibility. Participant eligibility includes ...

  6. GEN3013, Epcoritamab Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma EPCORE™ NHL-1 - Mayo Clinic

    About this study. The purpose of the trial is to determine the maximum tolerated dose and the recommended phase 2 dose as well as to establish the safety ...

  7. Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies - Mayo Clinic

    This is a Phase 2, uncontrolled, three-stage, ascending-dose-escalation study in subjects with one of three forms of TMA: atypical hemolytic uremic syndrome ...

  8. A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) - Mayo Clinic

    The purpose of this study is to select the optimal dose of naporafenib + trametinib to be studied in Stage 2 and to compare progression free survival (PFS) and ...

  9. A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens - Mayo Clinic

    This is a Phase 2, open-label, single arm study to evaluate the safety and efficacy of niraparib in ovarian cancer patients who have received three or four ...

  10. Sarcoma Clinical Trials

    Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...